S'abonner

Knowledge, interest, and motivations surrounding self-managed medication abortion among patients at three Texas clinics - 28/07/20

Doi : 10.1016/j.ajog.2020.02.026 
Abigail R.A. Aiken, PhD a, , Kathleen Broussard, MA b, Dana M. Johnson, MPAff a, Elisa Padron, BSc c, Jennifer E. Starling, MSc d, James G. Scott, PhD d
a LBJ School of Public Affairs, University of Texas at Austin, Austin, TX 
b Population Research Center, University of Texas at Austin, Austin, TX 
c College of Natural Sciences, University of Texas at Austin, Austin, TX 
d Department of Statistics and Data Science, University of Texas at Austin, Austin, TX 

Corresponding author: Abigail R.A. Aiken, PhD.

Abstract

Background

A rapid increase in restrictive abortion legislation in the United States has sparked renewed interest in self-managed abortion as a response to clinic access barriers. Yet little is known about knowledge of, interest in, and experiences of self-managed medication abortion among patients who obtain abortion care in a clinic.

Objectives

We examined patients’ knowledge of, interest in, and experience with self-managed medication abortion before presenting to the clinic. We characterized the clinic- and person-level factors associated with these measures. Finally, we examined the reasons why patients express an interest in or consider self-management before attending the clinic.

Materials and Methods

We surveyed 1502 abortion patients at 3 Texas clinics in McAllen, San Antonio, and Fort Worth. All individuals seeking abortion care who could complete the survey in English or Spanish were invited to participate in an anonymous survey conducted using iPads. The overall response rate was 90%. We examined the prevalence of 4 outcome variables, both overall and separately by site: (1) knowledge of self-managed medication abortion; (2) having considered self-managing using medications before attending the clinic; (3) interest in medication self-management as an alternative to accessing care at the clinic; and (4) having sought or tried any method of self-management before attending the clinic. We used binary logistic regression models to explore the clinic- and patient-level factors associated with these outcome variables. Finally, we analyzed the reasons reported by those who had considered medication self-management before attending the clinic, as well as the reasons reported by those who would be interested in medication self-management as an alternative to in-clinic care.

Results

Among all respondents, 30% knew about abortion medications available outside the clinic setting (37% in Fort Worth, 33% in McAllen, 19% in San Antonio, P < .001), and among those with prior knowledge, 28% had considered using this option before coming to the clinic (36% in McAllen, 25% in Fort Worth, 21% in San Antonio, P = .028). Among those without prior knowledge of self-management, 39% expressed interest in this option instead of coming to the clinic (54% in San Antonio, 30% in McAllen, 29% in Fort Worth, P < .001). Overall, 13% had sought out or tried any method of self-management before presenting to the clinic (16% in McAllen and 15% in Fort Worth vs 9% in San Antonio, P < .001). Experiencing barriers to clinic access was associated with having considered medication self-management (odds ratio, 2.2; 95% confidence interval, 1.7−3.0) and with seeking or trying any method of self-management before attending the clinic (odds ratio, 1.9; 95% confidence interval, 1.3−2.7). Difficulty affording the cost of in-clinic care was the most commonly cited reason for having considering medication self-management before attending the clinic. Reasons for interest in medication self-management as an alternative to clinic care included both access barriers and preferences for the privacy and comfort of home.

Conclusion

Considering or attempting self-managed abortion may be part of the pathway to seeking in-clinic care, particularly among those experiencing access barriers. However, considerable interest in medication self-management as an alternative to the clinic also suggests a demand for more autonomous abortion care options.

Le texte complet de cet article est disponible en PDF.

Key words : abortion, medication abortion, mifepristone, misoprostol, self-managed abortion, Texas


Plan


 The authors report no conflict of interest.
 This study was supported by funding from a Junior Investigator grant from the Society of Family Planning (SFPRF10-JI2). The study was also supported in part by infrastructure grant P2CHD042849 and training grant 5 T32 LM012414-03 awarded to The University of Texas at Austin by the National Institutes of Health. None of the funders had any role in the study design, data collection, data analysis, interpretation of data, the writing of the report or the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Society of Family Planning.
 Cite this article as: Aiken ARA, Broussard K, Johnson DM, et al. Knowledge, interest, and motivations surrounding self-managed medication abortion among patients at three Texas clinics. Am J Obstet Gynecol 2020;223:238.e1-10.


© 2020  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 223 - N° 2

P. 238.e1-238.e10 - août 2020 Retour au numéro
Article précédent Article précédent
  • Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling
  • Vinita Goyal, Isabel H. McLoughlin Brooks, Robin Wallace, Amna I. Dermish, Bhavik Kumar, Ann Schutt-Ainé, Anitra Beasley, Abigail R.A. Aiken, Joseph E. Potter
| Article suivant Article suivant
  • Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China
  • Yanting Wu, Chen Zhang, Han Liu, Chenchi Duan, Cheng Li, Jianxia Fan, Hong Li, Lei Chen, Hualin Xu, Xiangjuan Li, Yi Guo, Yeping Wang, Xiufeng Li, Jing Li, Ting Zhang, Yiping You, Hongmei Li, Shuangqi Yang, Xiaoling Tao, Yajuan Xu, Haihong Lao, Ming Wen, Yan Zhou, Junying Wang, Yuhua Chen, Diyun Meng, Jingli Zhai, Youchun Ye, Qinwen Zhong, Xiuping Yang, Dan Zhang, Jing Zhang, Xifeng Wu, Wei Chen, Cindy-Lee Dennis, He-feng Huang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.